Trial intelligence / Profile preview

Effect of remifentanil dose combined with target-controlled propofol anesthesia on sinus rhythm variability in children

2008-008598-72Phase 2Active

Sponsor
CHU de Lille
Start
Mar 2009
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of remifentanil and propofol (2 arms), sponsored by CHU de Lille. Primary endpoint: RR interval values. Started Mar 2009; status: active.

02

Drugs

remifentanilpropofol

Beyond the preview

Go deeper on 2008-008598-72.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008598-72.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call